Hospital General Universitario de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (45)

2019

  1. High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance

    Haematologica, Vol. 104, Núm. 11, pp. 2249-2257

2017

  1. Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes

    Cancer Letters, Vol. 409, pp. 42-48

  2. Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome

    Blood Transfusion, Vol. 15, Núm. 5, pp. 472-477

  3. Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload

    Clinical Biochemistry, Vol. 50, Núm. 16-17, pp. 911-917

  4. Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions

    Oncotarget, Vol. 8, Núm. 33, pp. 54297-54303

  5. Validation of R-MIPI and prognostic value of immunoglobulin light chain restriction in mantle cell lymphoma

    British Journal of Haematology

2015

  1. Extra-nodal B-cell non-Hodgkin's lymphomas of the head and neck: A study of 68 cases

    American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 36, Núm. 1, pp. 57-62

  2. Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia

    Leukemia and Lymphoma

2014

  1. Hairy cell leukemia treated initially with purine analogs: A retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)

    Leukemia and Lymphoma, Vol. 55, Núm. 5, pp. 1007-1012

  2. Increased oxidative damage associated with unfavorable cytogenetic subgroups in chronic lymphocytic leukemia

    BioMed Research International, Vol. 2014

  3. Simplification of risk stratification for splenic marginal zone lymphoma: A point-based score for practical use

    Leukemia and Lymphoma

  4. Vascular Endothelial Growth Factor a ( VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia

    PLoS ONE, Vol. 9, Núm. 6

2013

  1. Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does -7/7q- detection by FISH have prognostic value?

    Leukemia Research, Vol. 37, Núm. 4, pp. 416-421

  2. Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: Analysis of 627 patients with isolated 13q deletion

    British Journal of Haematology, Vol. 163, Núm. 1, pp. 47-54

  3. Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome

    Leukemia Research, Vol. 37, Núm. 7, pp. 769-776

  4. Hodgkin lymphoma in pregnancy: A case report

    Clinical Advances in Hematology and Oncology, Vol. 11, Núm. 8, pp. 533-536

  5. Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

    Blood, Vol. 122, Núm. 24, pp. 3951-3959

2012

  1. Chronic lymphocytic leukaemia with 17p deletion: A retrospective analysis of prognostic factors and therapy results

    British Journal of Haematology, Vol. 157, Núm. 1, pp. 67-74

  2. Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes

    British Journal of Haematology, Vol. 159, Núm. 3, pp. 311-321

  3. Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: Development and validation on 593 cases

    British Journal of Haematology, Vol. 159, Núm. 2, pp. 164-171